Role of oncostatin M in hematopoiesis and liver development

Cytokine and Growth Factor Reviews

Volumn 11, Issue 3, 2000, Pages 177-183

  Miyajima, Atsushi ^a,b   Kinoshita, Taisei ^a   Tanaka, Minoru ^b   Kamiya, Akihide ^b   Mukouyama, Yousuke ^a   Hara, Takahiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Cytokine; Hematopoiesis; Hepatocyte stem cell; Vasculogenesis

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GROWTH INHIBITOR; ONCOSTATIN M; ONCOSTATIN M RECEPTOR; PEPTIDE;

ANGIOGENESIS; ANIMAL; ANIMAL TISSUE; AORTA; CELL DIFFERENTIATION; CELL MIGRATION; CYTOKINE PRODUCTION; EMBRYO DEVELOPMENT; EMBRYOLOGY; GONAD; GROWTH, DEVELOPMENT AND AGING; HEMATOPOIESIS; HUMAN; LIVER; LIVER DEVELOPMENT; MESONEPHROS; METABOLISM; MOUSE; NONHUMAN; PHYSIOLOGY; SHORT SURVEY;

ANIMALS; AORTA; GONADS; GROWTH INHIBITORS; HEMATOPOIESIS; HUMANS; LIVER; MESONEPHROS; ONCOSTATIN M; PEPTIDES; RECEPTORS, CYTOKINE; RECEPTORS, ONCOSTATIN M;

EID: 0034119770     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(00)00003-4     Document Type: Short Survey

References (59)

1. Golin I., Dieterlen-Lievre F., Cumano A. Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. Proc. Natl. Acad. Sci. USA. 92:(3):1995;773-777. [published erratum appears in Proc Natl Acad Sci USA 1995 Nov 7;92(23):10815].
2. Delassus S., Cumano A. Circulation of hematopoietic progenitors in the mouse embryo. Immunity. 4:(1):1996;97-106.
3. Cumano A., Dieterlen-Lievre F., Godin I. Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell. 86:(6):1996;907-916.
4. Muller A.M., et al. Development of hematopoietic stem cell activity in the mouse embryo. Immunity. 1:(4):1994;291-301.
5. Dzierzak E., Medvinsky A., de Bruijn M. Qualitative and quantitative aspects of hematopoietic cell development in the mammalian embryo. Immunol. Today. 19:(5):1998;228-236.
6. Keller G., Lacaud G., Robertson S. Development of the hematopoietic system in the mouse. Exp. Hematol. 27:(5):1999;777-787.
7. Douarin N.M. An experimental analysis of liver development. Med. Biol. 53:(6):1975;427-455.
8. Houssaint E. Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation. Cell Differ. 9:(5):1980;269-279.
9. Johnson G.R., Moore M.A. Role of stem cell migration in initiation of mouse foetal liver hematopoietic. Nature. 258:(5537):1975;726-728.
10. Rose T.M., Bruce A.G. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl. Acad. Sci. USA. 88:(19):1991;8641-8645.
11. Bazan J.F. Neuropoietic cytokines in the hematopoietic fold. Neuron. 7:(2):1991;197-208.
12. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797-819.
13. Zarling J.M., et al. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc. Natl. Acad. Sci. USA. 83:(24):1986;9739-9743.
14. Gearing D.P., et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 255:(5050):1992;1434-1437.
15. Gascan H., et al. Characterization and NH2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor. Differentiation inhibitory activity secreted by a T lymphoma cell line. J. Biol. Chem. 264:(36):1989;21509-21515.
16. Bruce A.G., Hoggatt I.H., Rose T.M. Oncostatin M is a differentiation factor for myeloid leukemia cells. J. Immunol. 149:(4):1992;1271-1275.
17. Rose T.M., et al. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine. 6:(1):1994;48-54.
18. Richards C.D., et al. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148:(6):1992;1731-1736.
19. Baumann H., et al. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J. Biol. Chem. 268:(12):1993;8414-8417.
20. Miles S.A., et al. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science. 255:(5050):1992;1432-1434.
21. Richards C.D., et al. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J. Immunol. 150:(12):1993;5596-5603.
22. Mosley B., et al. Dual Oncostatin M (OSM) Receptors. Cloning and characterization of an alternative signaling subunit conferring osm-specific receptor activation. J. Biol. Chem. 271:(50):1996;32635-32643.
23. Thoma B., et al. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem. 269:(8):1994;6215-6222.
24. Yoshimura A., et al. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the HAK-STAT5 pathway. EMBO J. 15:(5):1996;1055-1063.
25. Ichihara M., et al. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mouse. Blood. 90:(1):1997;165-173.
26. Lindberg R.A., et al. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol. Cell. Biol. 18:(6):1998;3357-3367.
27. Tanaka M., et al. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Blood. 93:(3):1999;804-815.
28. Mukouyama Y., et al. In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity. 8:(1):1998;105-114.
29. Hara T., et al. Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region. Immunity. 11:(5):1999;567-578.
30. Sabin F.R. Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm if the chick during the second day incubation. Cell. 86:(3):1920;47-57.
31. Pardanaud L., et al. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development. 122:(5):1996;1363-1371.
32. Eichmann A., et al. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc. Natl. Acad. Sci. USA. 94:(10):1997;5141-5146.
33. Jaffredo T., et al. Intraaortic hematopoietic cells are derived from endothelial cells during ontogeny. Development. 125:(22):1998;4575-4583.
34. Shalaby F., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:(6535):1995;62-66.
35. Shalaby F., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:(6):1997;981-990.
36. Dickson M.C., et al. Defective hematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 121:(6):1995;1845-1854.
37. Porcher C., et al. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:(1):1996;47-57.
38. Visvader J.E., Fujiwara Y., Orkin S.H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:(4):1998;473-479.
39. Kershaw D.B., Thomas P.E., Wharram B.L., Goyal M., Wiggins J.E., Whiteside C.I., Wiggins R.C. Molecular cloning, expression, and characterization of podocalyxin-like protein 1 from rabbit as a transmembrane protein of glomerular podocytes and vascular endothelium. J. Biol. Chem. 270:(49):1995;29439-29446.
40. Kershaw D.B., Beck S.G., Wharram B.L., Wiggins J.E., Goyal M., Thomas P.E., Wiggins R.C. Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J. Biol. Chem. 272:(25):1997;15708-15714.
41. Sassetti C., Tangemann K., Singer M.S., Kershaw D.B., Rosen S.D. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J. Exp. Med. 187:(12):1998;1965-1975.
42. Mucenski M.L., et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 65:(4):1991;677-689.
43. Mukouyama Y., et al. Hematopoietic cells in cultures of the murine embryonic aorta-gonad-mesonephros region are induced by c-Myb. Curr. Biol. 9:(15):1999;833-836.
44. North T., et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 126:(11):1999;2563-2575.
45. Mukouyama Y, Chiba N, Hara T, Okada H, Kanamaru R, Miyajima A, Satake M, Watanabe T. The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region. Dev Biol 2000;220:27-36.
46. Panduro A., Shalaby F., Shafritz D.A. Changing patterns of transcriptional and post-transcriptional control of liver-specific gene expression during rat development. Genes Dev. 1:(10):1987;1172-1182.
47. Shiojiri N., Lemire J.M., Fausto N. Cell lineages and oval cell progenitors in rat liver development. Cancer Res. 51:1991;139-152.
48. Tilghman S.M., Belayew A. Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc. Natl. Acad. Sci. USA. 79:(17):1982;5254-5257.
49. Greengard O. The developmental formation of enzymes in rat liver. Litwack G. Biochemical actions of hormones. 1970;53-87 Academic Press Inc, New York.
50. Haber B.A., et al. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J. Clin. Invest. 95:(2):1995;832-841.
51. Nagao M., Nakamura T., Ichihara A. Developmental control of gene expression of tryptophan 2,3-dioxygenase in neonatal rat liver. Biochim. Biphys. Acta. 867:(4):1986;179-186.
52. Noda C., Ohguri M., Ichihara A. Developmental and growth-related regulation of expression of serine dehydratase mRNA in rat liver. Biochem. Biphys. Res. Commun. 168:(1):1990;335-342.
53. Nawa K., et al. Glucocorticoid-dependent expression of the albumin gene in adult rat hepatocytes. J. Biol. Chem. 261:(36):1986;16883-16888.
54. Belanger L., et al. Glucocorticosteroid suppression of alpha1-fetoprotein synthesis in developing rat liver. Evidence for selective gene repression at the transcriptional level. Biochemistry. 20:(23):1981;6665-6672.
55. Sanchez A., et al. Transforming growth factor beta modulates growth and differentiation of fetal hepatocytes in primary culture. J. Cell Physiol. 165:(2):1995;398-405.
56. Kamiya A., et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J. 18:(8):1999;2127-2136.
57. Yoshida K., et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:(1):1996;407-411.
58. Kinoshita T., et al. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc. Natl. Acad. Sci. USA. 86:(13):1999;7265-7270.
59. Nagasawa T., Tachibana K., Kishimoto T. A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin. Immuno. 10:(3):1998;179-185.